NDC codes

FDA NDC Directory
Product NDC (as listed)49230-191Labeler and product segments. Claims need a package NDC.
Product NDC at billing width49230-0191Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
49230-191-5049230019150492300191502 BAG in 1 CARTON (49230-191-50) / 5000 mL in 1 BAGMarketed from Nov 30, 1984
49230-191-5249230019152492300191522 BAG in 1 CARTON (49230-191-52) / 5000 mL in 1 BAGMarketed from Nov 30, 1984
49230-191-6249230019162492300191622 BAG in 1 CARTON (49230-191-62) / 6000 mL in 1 BAGMarketed from Nov 30, 1984

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Delflex
Generic name (nonproprietary)
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
Active ingredients
Dextrose monohydrate — 2.5 g/100mLSodium chloride — 567 mg/100mLSodium lactate — 392 mg/100mLCalcium chloride — 25.7 mg/100mLMagnesium chloride — 15.2 mg/100mL
Dosage form
Solution
Route
Intraperitoneal
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 018883
Marketing start
Listing expires
Other FDA classes
Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers
Product ID 49230-191_595790f1-c143-5ae9-e063-6294a90abd18SPL ID 595790f1-c143-5ae9-e063-6294a90abd18SPL set ID 515dcee0-3e34-11e2-a25f-0800200c9a66UNII LX22YL083G, TU7HW0W0QT, M4I0D6VV5M, 02F3473H9O, 451W47IQ8X
Pharmacologic class
Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N449230019150 followed by a unit qualifier and the quantity

Package 49230-0191-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

1. INDICATIONS AND USAGE DELFLEX® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis. For treatment of chronic kidney failure. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 49230-191

What is NDC 49230-191?
49230-191 is the product NDC for Delflex, Dextrose monohydrate 2.5 g/100mL + 4 more ingredients solution, listed with the FDA by Fresenius Medical Care Renal Therapies Group, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Delflex (Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride).
What is the active ingredient?
Dextrose monohydrate, Sodium chloride, Sodium lactate, Calcium chloride, Magnesium chloride.
Who is the labeler?
Fresenius Medical Care Renal Therapies Group, LLC, NDC labeler code 49230. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Delflex?
7 other product NDCs are listed under this name. See all Delflex NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Delflex NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chlorideDextrose monohydrate 1.5 g/100mL + 4 more ingredientsSolutionIntraperitonealFresenius Medical Care de Mexico, S.A. de C.V.46163-20646163-0206-9246163-0206-9446163-0206-95
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chlorideSodium chloride 538 mg/100mL + 4 more ingredientsSolutionIntraperitonealFresenius Medical Care de Mexico, S.A. de C.V.46163-20946163-0209-9246163-0209-9446163-0209-95
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chlorideDextrose monohydrate 4.25 g/100mL + 4 more ingredientsSolutionIntraperitonealFresenius Medical Care de Mexico, S.A. de C.V.46163-21246163-0212-9246163-0212-9446163-0212-95
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chlorideDextrose monohydrate 1.5 g/100mL + 4 more ingredientsSolutionIntraperitonealFresenius Medical Care Renal Therapies Group, LLC49230-20649230-0206-3049230-0206-3249230-0206-50+2 more
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chlorideSodium chloride 538 mg/100mL + 4 more ingredientsSolutionIntraperitonealFresenius Medical Care Renal Therapies Group, LLC49230-20949230-0209-3049230-0209-3249230-0209-50+2 more
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chlorideDextrose monohydrate 4.25 g/100mL + 4 more ingredientsSolutionIntraperitonealFresenius Medical Care Renal Therapies Group, LLC49230-21249230-0212-9249230-0212-9449230-0212-95
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chlorideDextrose monohydrate 1.5 g/100mL + 4 more ingredientsSolutionIntraperitonealFresenius Medical Care Renal Therapies Group, LLC49230-18849230-0188-5049230-0188-5249230-0188-62

Other NDCs under NDA 018883

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018883
ProductStrengthForm · routeLabelerProduct NDC
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chlorideDextrose monohydrate 1.5 g/100mL + 4 more ingredientsSolutionIntraperitonealFresenius Medical Care Renal Therapies Group, LLC49230-188

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in